ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 92 filers reported holding ADMA BIOLOGICS INC in Q1 2020. The put-call ratio across all filers is 1.46 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $225,000 | -21.1% | 94,100 | -3.1% | 0.04% | -29.5% |
| Q2 2020 | $285,000 | +32.6% | 97,100 | +30.2% | 0.06% | -27.4% |
| Q1 2020 | $215,000 | -27.9% | 74,600 | 0.0% | 0.08% | +75.0% |
| Q4 2019 | $298,000 | -37.1% | 74,600 | -30.0% | 0.05% | -54.7% |
| Q3 2019 | $474,000 | +19.4% | 106,500 | +3.8% | 0.11% | +68.3% |
| Q2 2019 | $397,000 | +70.4% | 102,608 | +67.4% | 0.06% | +40.0% |
| Q1 2019 | $233,000 | +94.2% | 61,300 | +22.6% | 0.04% | +50.0% |
| Q4 2018 | $120,000 | -80.7% | 50,000 | -50.0% | 0.03% | -64.3% |
| Q3 2018 | $621,000 | +72.0% | 100,000 | +25.0% | 0.08% | +55.6% |
| Q2 2018 | $361,000 | – | 80,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Velan Capital Investment Management LP | 4,000,000 | $15,520,000 | 13.71% |
| Stonepine Capital Management, LLC | 6,940,000 | $26,927,200 | 11.33% |
| Caligan Partners LP | 2,676,093 | $10,383,241 | 8.64% |
| Altium Capital Management LP | 2,870,000 | $11,135,600 | 5.66% |
| AWM Investment Company, Inc. | 6,015,000 | $23,338,200 | 3.36% |
| EAM Investors, LLC | 1,749,598 | $6,788,440 | 1.40% |
| Perceptive Advisors | 11,900,255 | $46,172,989 | 1.30% |
| EAM Global Investors LLC | 836,323 | $3,244,933 | 0.84% |
| Potomac Capital Management, Inc. | 120,000 | $466 | 0.54% |
| OBERWEIS ASSET MANAGEMENT INC/ | 536,900 | $2,083,172 | 0.44% |